Verwendung von Nucleosiden, Nucleobasen und deren Derivaten zum Herabsetzen toxischer Nebenwirkungen von Cytostatika

This invention concerns the use of nucleosides, nucleobases, and their derivatives, particularly of 6-methyluracil, for reducing toxic side effects of cytostatic agents. Also disclosed are combined preparations of nucleosides, nucleobases and their derivatives and cytostatic agents.

Saved in:
Bibliographic Details
Main Authors LANGEN, PETER, , 13125 BERLIN, DE, SCHUETT, MANFRED., 13125 BERLIN, DE, FICHTNER, IDUNA., 13125 BERLIN, DE, KOBERLING, ANNEMARIE, 16341 ZEPERNICK, DE, IHN, LISELOTTE, 10318 BERLIN, DE
Format Patent
LanguageGerman
Published 10.06.1998
Edition6
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:This invention concerns the use of nucleosides, nucleobases, and their derivatives, particularly of 6-methyluracil, for reducing toxic side effects of cytostatic agents. Also disclosed are combined preparations of nucleosides, nucleobases and their derivatives and cytostatic agents.
Bibliography:Application Number: DE1996152418